Reduce suffering and improve the general wellness of millions of patients with incontinent associated skin problems.
Establish Dynamic Oxygen Skin Therapy (DOST™) as the standard of care.
RashEndZ, Inc. is the medical device start-up that patented the world’s first non-occludable, non-cloggable skin aeration technology, REZair™, for the millions of people suffering from incontinence. REZair™ connects to any consumer respiratory air or oxygen source, and circulates it directly to the adult or child’s garment/diaper-covered skin. This results in significant improvement in incontinent skin health for all patients.
This new therapy, Dynamic Oxygen Skin Therapy (DOST™), delivers the soothing comfort of continuous wetness reduction and increased oxygenation of the skin, day or night. DOST™ therapy was developed by a level III Neonatal Intensive Care (NICU III) nurse in pursuit of a therapy for her pre-mature babies with severe diaper rash. This early intervention preventative modality has never been available before REZair™. DOST™ therapy has been successfully clinically tested since 2015 in nursing homes, in the hospital, and in the home. The benefits of this new therapy has been reduced length of care, reduced cost of care, and improved quality of care.
Physicians may also prescribe REZair™ with the use of therapeutic oxygen, for a variety of wound care applications, such as those described in the following published papers.
81 Prospect Street
Brooklyn, NY 11201
Mon - Fri: 9AM to 5PM
Sat - Sun: Closed
Phone: (877) 218-3391
Your browser does not support HTML5 video.